Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
Home
Michael E. Thase, MD: Editor’s Letter
Michael E. Thase, MD: Editor’s Letter
$
0.00
Michael E. Thase, MD: Editor's Letter quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 40 No. 3 Articles
Tags:
editors-letter
,
invited-commentary
,
michael-e-thase
,
negative-and-failed-clinical-trial-reports
Description
Description
Michael E. Thase, MD
EDITOR’S LETTER
T
WO
N
EW
S
ECTIONS
O
FFER
F
URTHER
C
HECKS AND
B
ALANCES
: N
EGATIVE AND
F
AILED
C
LINICAL
T
RIAL
R
EPORTS AND
I
NVITED
C
OMMENTARY
Michael E. Thase, MD
Related products
Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening
$
30.00
Add to cart
Details
Jodi M. Gonzalez, PhD: Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder
$
30.00
Add to cart
Details
Assessing Rates and Predictors of Tachyphylaxis
$
30.00
Add to cart
Details
Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy
$
30.00
Add to cart
Details
Page load link
Go to Top
Michael E. Thase, MD: Editor’s Letter
$0.00
Description
Michael E. Thase, MD
EDITOR’S LETTER
TWO NEW SECTIONS OFFER FURTHER CHECKS AND BALANCES: NEGATIVE AND FAILED CLINICAL TRIAL REPORTS AND INVITED COMMENTARY
Michael E. Thase, MD
Related products
Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening
Jodi M. Gonzalez, PhD: Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder
Assessing Rates and Predictors of Tachyphylaxis
Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy